Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
3401 - 3425 of 9034 Results
Title
Year
  • Year
  • 2025
  • 2026
  • 2011
  • 2019
  • 2017
  • 2017
  • 2019
  • 2013
  • 2012
  • 2018
  • 2010
  • 2017
  • 2005
  • 2014
  • 2026
  • 2020
  • 2021
  • 2023
  • 2010
  • 2025
  • 2018
  • 2018
  • 2024
  • 2024
  • 2018
  • Evaluation of a Mitochondrial Polygenic Score for Parkinson's Disease Across Ancestries
    2025
    Summary Details
    OPEN
    Title: Evaluation of a Mitochondrial Polygenic Score for Parkinson's Disease Across Ancestries
    Author(s): Joshua Chin Ern Ooi, Yi Wen Tay, Ai Huey Tan, Chin‐Hsien Lin, Kajsa Brolin, Björn‐Hergen Laabs, Sebastian Sendel, Inke R. König, Amke Caliebe, Carolin Gabbert, Katherine M. Andersh, Lietsel Jones, Lara M. Lange, Brian P. Fiske, Carolyn M. Sue, Christine Klein, Joanne Trinh, Theresa Lüth, The Global Parkinson's Genetics Program (GP2)
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 40
    Issue #: 9
    Start Page: 2015
    End Page: 2018
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/mds.30285
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.30285
    Citation Count: 2
  • Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
    2026
    Summary Details
    OPEN
    Title: Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
    Author(s): Paulina Gonzalez‐Latapi, Caroline Gochanour, Seung Ho Choi, H. A. Cho, Chelsea Caspell‐Garcia, Christopher Coffey, Michael C. Brumm, David‐Erick Lafontant, Yuge Xiao, Thomas Tropea, John Seibyl, Cary Tanner, Charles S. Venuto, Karl Kieburtz, Lana M. Chahine, Kathleen L. Poston, Andrew Siderowf, Kenneth Marek, Tanya Simuni, The Parkinson's Progression Markers Initiative
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Vol:
    Issue #:
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/acn3.70323
    Best OA location URL: https://doi.org/10.1002/acn3.70323
    Citation Count: 1
  • Biomarkers for Parkinson’s Disease
    2011
    Summary Details
    RESTRICTED
    Title: Biomarkers for Parkinson’s Disease
    Author(s): Todd Sherer
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Vol: 3
    Issue #: 79
    Start Page: 79ps14
    End Page: 79ps14
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.3002488
    Citation Count: 42
  • NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)
    2019
    Summary Details
    RESTRICTED
    Title: NILO-PD: A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s Disease: Study Design and Status Update (P3.8-035)
    Author(s): Tanya Simuni, Brian Fiske, Kalpana Merchant, Christopher S. Coffey, Helen Matthews, Richard Wyse, Patrik Brundin, David K. Simon, Michael A. Schwarzschild, David M. Weiner, Jamie Adams, Charles S. Venuto, Laura Trusso, Liana Baker, Melissa Kostrzebski, Tina P. Ward, Gary Rafaloff
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 92
    Issue #: 15_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.92.15_supplement.p3.8-035
    Citation Count: 2
  • Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)
    2017
    Summary Details
    RESTRICTED
    Title: Fox Insight: a Large-Scale Web-Enabled Parkinson’s Disease Study (P4.007)
    Author(s): Lana M. Chahine, Chelsea Caspell‐Garcia, Lauren P. McLaughlin, Connie Marras, David G. Standaert, Bernard Ravina, Christopher Kenney, Sohini Chowdhury, Todd Sherer, Catherine Kopil
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 88
    Issue #: 16_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p4.007
    Citation Count: 0
  • Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)
    2017
    Summary Details
    RESTRICTED
    Title: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)
    Author(s): Carly Linder, Christopher S. Coffey, Thomas G. Beach, Tatiana Foroud, Charles H. Adler, Holly Riss, Dixie Ecklund, Chelsea Caspell‐Garcia, Kuldip D. Dave, Sampada Deshpande, Shirley Lasch, Vanessa Arnedo, Lindsey Riley, Danna Jennings, Brit Mollenhauer, Lana M. Chahine
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 88
    Issue #: 16_supplement
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013
    Citation Count: 0
  • Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience Data
    2019
    Summary Details
    OPEN
    Title: Abstract #81: Improving Neurostimulation Clinical Trial Design with Patient Experience Data
    Author(s): Heather L. Benz, Brittany Caldwell, John P. Ruiz, Anindita Saha, Martin Ho, Stephanie Christopher, D. Bardot, Margaret Sheehan, Anne Donnelly, Lauren P. McLaughlin, Brennan Mange, Brett Hauber, Katrina Gwinn, Murray Sheldon
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Vol: 12
    Issue #: 2
    Start Page: e28
    End Page: e29
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2018.12.088
    Best OA location URL: https://doaj.org/article/33431349c85d454db7ad2af33222a015
    Citation Count: 0
  • Announcing a New Continuing Medical Education Course
    2013
    Summary Details
    RESTRICTED
    Title: Announcing a New Continuing Medical Education Course
    Author(s): Joseph H. Friedman
    Journal Name: Cognitive and Behavioral Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 26
    Issue #: 2
    Start Page: 56
    End Page: 58
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wnn.0b013e31829af2fb
    Citation Count: 1
  • P4‐308: CSF α‐synuclein, BETA‐AMYLOID 1–42 and tau proteins: Relationship to clinical parameters in early Parkinson's disease
    2012
    Summary Details
    RESTRICTED
    Title: P4‐308: CSF α‐synuclein, BETA‐AMYLOID 1–42 and tau proteins: Relationship to clinical parameters in early Parkinson's disease
    Author(s): Ju‐Hee Kang, Alice Chen‐Plotkin, David J. Irwin, Andrew Siderowf, Chelsea Caspell, Christopher S. Coffey, Peggy Taylor, Mark Frasier, Kenneth Marek, Brit Mollenhauer, John Q. Trojanowski, Leslie M. Shaw
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Vol: 8
    Issue #: 4S_Part_21
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2013.08.089
    Citation Count: 0
  • Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review
    2018
    Summary Details
    RESTRICTED
    Title: Pimavanserin for Psychotic Symptoms in People With Parkinsonism: A Second Chart Review
    Author(s): Joseph H. Friedman
    Journal Name: Clinical Neuropharmacology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 41
    Issue #: 5
    Start Page: 156
    End Page: 159
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1097/wnf.0000000000000296
    Citation Count: 12
  • Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease
    2010
    Summary Details
    RESTRICTED
    Title: Qualitative Imaging of Adeno-Associated Virus Serotype 2–Human Aromatic L-Amino Acid Decarboxylase Gene Therapy in a Phase I Study for the Treatment of Parkinson Disease
    Author(s): Francisco Valles, Massimo S. Fiandaca, Jamie L. Eberling, Philip A. Starr, Paul Larson, Chadwick W. Christine, John Forsayeth, R. Mark Richardson, Lei Su, Michael J. Aminoff, Krystof S. Bankiewicz
    Journal Name: Neurosurgery
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 67
    Issue #: 5
    Start Page: 1377
    End Page: 1385
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1227/neu.0b013e3181f53a5c
    Citation Count: 71
  • Beliefs About Use of Complementary Health Approaches for Parkinson's Disease
    2017
    Summary Details
    OPEN
    Title: Beliefs About Use of Complementary Health Approaches for Parkinson's Disease
    Author(s): Ju Young Shin, Ryan T. Pohlig, Barbara Habermann
    Journal Name: Holistic Nursing Practice
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Vol: 31
    Issue #: 5
    Start Page: 290
    End Page: 294
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1097/hnp.0000000000000229
    Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5664950
    Citation Count: 0
  • Paraquat Neurotoxicity is Distinct from that of MPTP and Rotenone
    2005
    Summary Details
    OPEN
    Title: Paraquat Neurotoxicity is Distinct from that of MPTP and Rotenone
    Author(s): Jason R. Richardson, Quan Yu, Todd Sherer, J. Timothy Greenamyre, Gary W. Miller
    Journal Name: Toxicological Sciences
    Publisher: Oxford University Press (OUP)
    Vol: 88
    Issue #: 1
    Start Page: 193
    End Page: 201
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/toxsci/kfi304
    Best OA location URL: https://academic.oup.com/toxsci/article-pdf/88/1/193/4676394/kfi304.pdf
    Citation Count: 269
  • Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
    2014
    Summary Details
    OPEN
    Title: Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury
    Author(s): Nigel H. Greig, David Tweedie, Lital Rachmany, Yazhou Li, Vardit Rubovitch, Shaul Schreiber, Yung‐Hsiao Chiang, Barry J. Hoffer, Jonathan P. Miller, Debomoy K. Lahiri, Kumar Sambamurti, Robert E. Becker, Chaim G. Pick
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Vol: 10
    Issue #: 1S
    Start Page: S62
    End Page: 75
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.jalz.2013.12.011
    Best OA location URL: http://doi.org/10.1016/j.jalz.2013.12.011
    Citation Count: 70
  • fMRI-based deep brain stimulation programming for Parkinson's disease: a blinded, crossover clinical trial
    2026
    Summary Details
    OPEN
    Title: fMRI-based deep brain stimulation programming for Parkinson's disease: a blinded, crossover clinical trial
    Author(s): Brendan Santyr, Alexandre Boutet, Jurgen Germann, Jianwei Qiu, Aaron Loh, Ibrahim Alhashyan, Clement T. Chow, Can Sarica, Artur Vetkas, Andrew Yang, Gavin Elias, Stefan Lang, Mojgan Hodaie, Suneil K. Kalia, A. Fasano, Afis Ajala, Andres M. Lozano
    Journal Name: Brain Stimulation
    Publisher: Elsevier BV
    Vol: 19
    Issue #: 2
    Start Page: 103069
    End Page: 103069
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.brs.2026.103069
    Best OA location URL: https://www.brainstimjrnl.com/article/S1935-861X(26)00046-X/pdf
    Citation Count: 1
  • Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
    2020
    Summary Details
    OPEN
    Title: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's Disease
    Author(s): Marina Picillo, Onanong Phokaewvarangkul, Yu‐Yan Poon, Cameron C. McIntyre, Sinem Balta Beylergil, Renato P. Munhoz, Suneil K. Kalia, Mojgan Hodaie, Andrés M. Lozano, Alfonso Fasano
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 36
    Issue #: 3
    Start Page: 672
    End Page: 680
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28382
    Best OA location URL: https://doi.org/10.1002/mds.28382
    Citation Count: 23
  • Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s Disease
    2021
    Summary Details
    OPEN
    Title: Patient-Centered Identification of Meaningful Regulatory Endpoints for Medical Devices to Treat Parkinson’s Disease
    Author(s): Heather L. Benz, Brittany Caldwell, John P. Ruiz, Anindita Saha, Martin Ho, Stephanie Christopher, D. Bardot, Margaret Sheehan, Anne Donnelly, Lauren P. McLaughlin, Brennan Mange, Brett Hauber, Katrina Gwinn, William Heetderks, Murray Sheldon
    Journal Name: MDM Policy & Practice
    Publisher: SAGE Publications
    Vol: 6
    Issue #: 1
    Start Page: 23814683211021380
    End Page: 23814683211021380
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1177/23814683211021380
    Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/23814683211021380
    Citation Count: 14
  • Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization
    2023
    Summary Details
    OPEN
    Title: Doubly Constrained C-terminal of Roc (COR) Domain-Derived Peptides Inhibit Leucine-Rich Repeat Kinase 2 (LRRK2) Dimerization
    Author(s): Pragya Pathak, Krista K. Alexander, Leah G. Helton, Michalis Kentros, Timothy J. LeClair, Xiaojuan Zhang, Franz Y. Ho, Timothy T. Moore, Scotty Hall, Giambattista Guaitoli, Christian Johannes Gloeckner, Arjan Kortholt, Hardy J. Rideout, Eileen J. Kennedy
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Vol: 14
    Issue #: 11
    Start Page: 1971
    End Page: 1980
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.3c00259
    Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.3c00259
    Citation Count: 24
  • Mitochondrial therapies for Parkinson's disease
    2010
    Summary Details
    OPEN
    Title: Mitochondrial therapies for Parkinson's disease
    Author(s): Bobby Thomas, M. Flint Beal
    Journal Name: Movement Disorders
    Publisher: Wiley
    Vol: 25
    Issue #: S1
    Start Page: S155
    End Page: 60
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.22781
    Best OA location URL: http://doi.org/10.1002/mds.22781
    Citation Count: 62
  • Dysphagia Is Associated with Incident Non‐Motor Symptoms in Parkinson's Disease
    2025
    Summary Details
    RESTRICTED
    Title: Dysphagia Is Associated with Incident Non‐Motor Symptoms in Parkinson's Disease
    Author(s): Muhammad Abdul Rehman, Rodolfo Savica, Revati Varma, Robert A. Vierkant, Kent R. Bailey, Adil E. Bharucha
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Vol: 12
    Issue #: 11
    Start Page: 1909
    End Page: 1924
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mdc3.70297
    Citation Count: 0
  • PINK 1 autophosphorylation is required for ubiquitin recognition
    2018
    Summary Details
    OPEN
    Title: PINK 1 autophosphorylation is required for ubiquitin recognition
    Author(s): Shafqat Rasool, Naoto Soya, Luc Truong, Nathalie Croteau, Gergely L. Lukács, Jean‐François Trempe
    Journal Name: The EMBO Reports
    Publisher: Springer Science and Business Media LLC
    Vol: 19
    Issue #: 4
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embr.201744981
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.15252/embr.201744981
    Citation Count: 117
  • Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation
    2018
    Summary Details
    RESTRICTED
    Title: Dopaminergic dose adjustment and negative affective symptoms after deep brain stimulation
    Author(s): Tamour Khan Tareen, Carlo Alberto Artusi, Federico Rodríguez‐Porcel, Johnna Devoto, Habibullah Sheikh, George Mandybur, Andrew P. Duker, Alberto J. Espay, Aristide Merola
    Journal Name: Journal of the Neurological Sciences
    Publisher: Elsevier BV
    Vol: 390
    Issue #:
    Start Page: 33
    End Page: 35
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jns.2018.04.002
    Citation Count: 2
  • What Parkinson's disease patients say in their own words about their mood and anxiety symptoms
    2024
    Summary Details
    RESTRICTED
    Title: What Parkinson's disease patients say in their own words about their mood and anxiety symptoms
    Author(s): Karen E. Anderson, Connie Marras, Amy W. Amara, Lana M. Chahine, Shirley Eberly, Abhishek Hosamath, Daniel Kinel, Sneha Mantri, Soania Mathur, David Oakes, Jennifer L. Purks, David G. Standaert, Daniel Weintraub, Ira Shoulson, Lakshmi Arbatti
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 130
    Issue #:
    Start Page: 107190
    End Page: 107190
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107190
    Citation Count: 3
  • Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial
    2024
    Summary Details
    OPEN
    Title: Efficacy of biologically-directed daylight therapy on sleep and circadian rhythm in Parkinson's disease: a randomised, double-blind, parallel-group, active-controlled, phase 2 clinical trial
    Author(s): Beatrix Feigl, Simon J.G. Lewis, Lucy Burr, Daniel Schweitzer, Subodh Gnyawali, Dimitrios Vagenas, Drew D. Carter, Andrew J. Zele
    Journal Name: eClinicalMedicine
    Publisher: Elsevier BV
    Vol: 69
    Issue #:
    Start Page: 102474
    End Page: 102474
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.eclinm.2024.102474
    Best OA location URL: http://www.thelancet.com/article/S2589537024000531/pdf
    Citation Count: 26
  • Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
    2018
    Summary Details
    OPEN
    Title: Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB
    Author(s): Run Yan, Jie Zhang, Hye-Jin Park, Eun Su Park, Stephanie Oh, Haiyan Zheng, Eunsung Junn, Michael Voronkov, Jeffry B. Stock, M. Maral Mouradian
    Journal Name: Proceedings of the National Academy of Sciences
    Publisher: National Academy of Sciences
    Vol: 115
    Issue #: 51
    Start Page: E12053
    End Page: E12062
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1073/pnas.1813365115
    Best OA location URL: https://www.pnas.org/content/pnas/115/51/E12053.full.pdf
    Citation Count: 92
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.